Home › Borstkanker › Virginia › Arlington
Borstkanker klinische studies in Arlington, VA
46 studies voor Borstkanker zoeken deelnemers op locaties in en rond Arlington (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekruterenFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
RekruterenFase 2
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
RekruterenFase 1/2
- Inova Schar Cancer Institute, Fairfax · 11 mijl verwijderd
- Virginia Cancer Specialists, PC, Fairfax · 11 mijl verwijderd
Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy
RekruterenFase 3
- Inova Schar Cancer Institute, Fairfax · 11 mijl verwijderd
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
RekruterenFase 2
- Inova Schar Cancer Institute, Fairfax · 11 mijl verwijderd
Study of AVZO-021 in Patients With Advanced Solid Tumors
RekruterenFase 1/2
- Avenzo Therapeutics Recruiting Site, Fairfax · 11 mijl verwijderd
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
RekruterenFase 3
- Inova Schar Cancer Institute ( Site 0025), Fairfax · 11 mijl verwijderd
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
RekruterenFase 3
- Research Site, Fairfax · 11 mijl verwijderd
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
RekruterenFase 2
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Rekruteren
- Inova, Fairfax · 11 mijl verwijderd
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RekruterenFase 3
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
RekruterenFase 2
- Inova Schar Cancer Institute, Fairfax · 11 mijl verwijderd
A Study of JNJ-101684362 (HLD-0117) in Patients With Metastatic Breast Cancer
RekruterenFase 1
- Next Virginia, Fairfax · 11 mijl verwijderd
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
RekruterenFase 1/2
- NEXT Oncology, Fairfax · 11 mijl verwijderd
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RekruterenFase 3
- Inova Schar Cancer Institute, Fairfax · 11 mijl verwijderd
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
RekruterenFase 1
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
A Phase 1/1b Study of IAM1363 in HER2 Cancers
RekruterenFase 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
RekruterenFase 1
- NEXT Oncology, Fairfax · 11 mijl verwijderd
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
RekruterenFase 1/2
- Virginia Cancer Specialists-Fairfax, Fairfax · 11 mijl verwijderd
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
RekruterenFase 1/2
- Next Oncology, Fairfax · 11 mijl verwijderd
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
RekruterenFase 3
- Virginia Cancer Specialists, PC, Fairfax · 11 mijl verwijderd
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
RekruterenFase 1/2
- NEXT Virginia, Fairfax · 11 mijl verwijderd
The Vanguard Study: Testing a New Way to Screen for Cancer
RekruterenGezonde vrijwilligers welkom
- Inova Schar Cancer Institute, Fairfax · 11 mijl verwijderd
- Inova Fair Oaks Hospital, Fairfax · 11 mijl verwijderd
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekruterenFase 3
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 mijl verwijderd
- Kaiser Permanente-Burke Medical Center, Burke · 11 mijl verwijderd
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
RekruterenFase 1
- NEXT Virginia, Fairfax · 11 mijl verwijderd
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
RekruterenFase 1
- NEXT Virginia, Fairfax · 11 mijl verwijderd
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
RekruterenFase 1
- Inova Schar Cancer Institute, Falls Church · 4 mijl verwijderd
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
RekruterenFase 3
- Inova Schar Cancer Institute, Fairfax · 11 mijl verwijderd
- Inova Fair Oaks Hospital, Fairfax · 11 mijl verwijderd
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
RekruterenFase 3
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RekruterenFase 1/2
- USOR Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
E-Mindfulness Approaches for Living After Breast Cancer
RekruterenFase 3
- Inova Fairfax Hospital, Falls Church · 4 mijl verwijderd
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 mijl verwijderd
- Inova Schar Cancer Institute, Fairfax · 11 mijl verwijderd
- en nog 1
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
RekruterenFase 1
- NEXT Virginia, Fairfax · 11 mijl verwijderd
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
RekruterenFase 1/2
- USO-Virginia Cancer Specialists, PC, Fairfax · 11 mijl verwijderd
Pre-Operative Window of ET to Inform RT Decisions (POWER II)
RekruterenFase 3
- INOVA Schar Cancer, Fairfax · 11 mijl verwijderd
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
RekruterenFase 1/2
- NEXT Oncology Virginia, Fairfax · 11 mijl verwijderd
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
RekruterenFase 1/2
- NEXT, Fairfax · 11 mijl verwijderd
Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer
RekruterenFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)
RekruterenFase 1/2
- Inova Schar Cancer Institute ( Site 0051), Fairfax · 11 mijl verwijderd
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
RekruterenFase 3
- Virginia Cancer Specialists, PC, Reston · 14 mijl verwijderd
- Virginia Cancer Specialists, Manassas · 22 mijl verwijderd
A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
RekruterenFase 1
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
RekruterenFase 1
- NEXT Oncology Virginia, Fairfax · 11 mijl verwijderd
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
RekruterenFase 1/2
- NEXT Virginia, Fairfax · 11 mijl verwijderd
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
RekruterenFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
RekruterenFase 1/2
- NEXT, Virginia, Fairfax · 11 mijl verwijderd
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
RekruterenFase 1
- Inova Schar Cancer Center, Fairfax · 11 mijl verwijderd
- NEXT Virginia, Fairfax · 11 mijl verwijderd
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced and/or Metastatic Breast Cancer
RekruterenFase 1
- Biotheryx Investigative Site, Fairfax · 11 mijl verwijderd
Borstkanker studies in andere steden
- New York City, NY134 studies
- Houston, TX126 studies
- Boston, MA111 studies
- Nashville, TN80 studies
- Los Angeles, CA72 studies
- Edison, NJ68 studies
- St. Louis, MO64 studies
- Durham, NC63 studies
- Queens, NY63 studies
- Chicago, IL58 studies
- Philadelphia, PA56 studies
- Dallas, TX55 studies
Andere studies in Arlington
- Niet-kleincellige longkanker104 studies
- Metastatische kanker53 studies
- Colorectale kanker52 studies
- Kanker (alle vormen)48 studies
- Eierstokkanker46 studies
- Longkanker41 studies
- Endometriumkanker39 studies
- Aldermeesklierkanker33 studies
- Plaveiselcelcarcinoom van hoofd en hals26 studies
- Kleincellige longkanker23 studies
- Drievoudig negatieve borstkanker20 studies
- Maagkanker20 studies
Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.